Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1990 2
1998 1
1999 1
2006 1
2008 1
2010 1
2011 2
2012 4
2013 5
2014 6
2015 4
2016 3
2017 1
2018 7
2019 7
2020 10
2021 5
2022 6
2023 4
2024 1
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Rotaviruses: From Pathogenesis to Disease Control-A Critical Review.
Omatola CA, Olaniran AO. Omatola CA, et al. Viruses. 2022 Apr 22;14(5):875. doi: 10.3390/v14050875. Viruses. 2022. PMID: 35632617 Free PMC article. Review.
Since their first recognition in human cases about four decades ago, rotaviruses have remained the leading cause of acute severe dehydrating diarrhea among infants and young children worldwide. The WHO prequalification of oral rotavirus vaccines (ORV) a decad …
Since their first recognition in human cases about four decades ago, rotaviruses have remained the leading cause of acute severe dehydrating …
Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network.
Fitzpatrick T, Alsager K, Sadarangani M, Pham-Huy A, Murguía-Favela L, Morris SK, Seow CH, Piché-Renaud PP, Jadavji T, Vanderkooi OG, Top KA, Constantinescu C; Special Immunization Clinic Network investigators. Fitzpatrick T, et al. Lancet Child Adolesc Health. 2023 Sep;7(9):648-656. doi: 10.1016/S2352-4642(23)00136-0. Epub 2023 Jun 27. Lancet Child Adolesc Health. 2023. PMID: 37390832
We aimed to examine whether live rotavirus vaccine could be administered safely to infants exposed to biologic agents, assessed in the Canadian Special Immunization Clinic (SIC) Network. ...Data were collected for relevant medical history, pregnancy ou …
We aimed to examine whether live rotavirus vaccine could be administered safely to infants exposed to biologic a …
In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration.
Berkhout A, Clark JE, Wen SC. Berkhout A, et al. Expert Rev Vaccines. 2019 May;18(5):495-504. doi: 10.1080/14760584.2019.1599286. Epub 2019 Apr 5. Expert Rev Vaccines. 2019. PMID: 30916600 Review.
As a result, this significantly impacts receipt of rotavirus vaccination, a vaccine recommended in many countries' national immunization program. Area covered: We have reviewed all available published literature to explore the effect of peripartum bDMARDS exposur
As a result, this significantly impacts receipt of rotavirus vaccination, a vaccine recommended in many countries' national im …
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.
Cunliffe N, Zaman K, Rodrigo C, Debrus S, Benninghoff B, Pemmaraju Venkata S, Han HH. Cunliffe N, et al. BMC Pediatr. 2014 Nov 30;14:295. doi: 10.1186/s12887-014-0295-2. BMC Pediatr. 2014. PMID: 25433534 Free PMC article. Review.
BACKGROUND: Rotaviruses are the leading cause of severe acute gastroenteritis in children aged <5 years worldwide. A live attenuated human rotavirus vaccine, RIX4414 has been developed to reduce the global disease burden associated with rotavirus gastroent …
BACKGROUND: Rotaviruses are the leading cause of severe acute gastroenteritis in children aged <5 years worldwide. A live attenuated huma …
In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
Kazimbaya KM, Chisenga CC, Simuyandi M, Phiri CM, Laban NM, Bosomprah S, Permar SR, Munsaka S, Chilengi R. Kazimbaya KM, et al. PLoS One. 2020 Nov 10;15(11):e0240714. doi: 10.1371/journal.pone.0240714. eCollection 2020. PLoS One. 2020. PMID: 33170860 Free PMC article.
BACKGROUND: Despite contributing to a significant reduction in rotavirus associated diarrhoea in highly burdened low- and middle-income countries, live attenuated, oral rotavirus vaccines have lower immunogenicity and efficacy in these settings in comparison …
BACKGROUND: Despite contributing to a significant reduction in rotavirus associated diarrhoea in highly burdened low- and middle-inco …
Rotavirus vaccine trial in Jamaica.
Christie CD, Duncan ND. Christie CD, et al. West Indian Med J. 2012 Jul;61(4):405-7. doi: 10.7727/wimj.2012.219. West Indian Med J. 2012. PMID: 23240476 Clinical Trial.
Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, …
Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity a …
Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.
Doll MK, Buckeridge DL, Morrison KT, Gagneur A, Tapiero B, Charest H, Quach C. Doll MK, et al. Vaccine. 2015 Dec 16;33(51):7307-7314. doi: 10.1016/j.vaccine.2015.10.118. Epub 2015 Nov 3. Vaccine. 2015. PMID: 26546262
BACKGROUND AND OBJECTIVES: We assessed monovalent rotavirus (RV1) vaccine effectiveness (VE) in a high-income setting with RV1 predominant use, and examined the burden of pediatric rotavirus gastroenteritis following the implementation of an RV1-only vaccinat …
BACKGROUND AND OBJECTIVES: We assessed monovalent rotavirus (RV1) vaccine effectiveness (VE) in a high-income setting with RV1 …
Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review.
Schell TL, Fass L, Hitchcock ME, Farraye FA, Hayney MS, Saha S, Caldera F. Schell TL, et al. Inflamm Bowel Dis. 2025 Jul 7;31(7):1789-1796. doi: 10.1093/ibd/izae220. Inflamm Bowel Dis. 2025. PMID: 39303214 Free article.
BACKGROUND: In infants that were exposed to biologics in utero, gastroenterology societal guidelines have either recommended against administration of the live rotavirus vaccine until 6-12 months of age or until serum biologic levels are undetec …
BACKGROUND: In infants that were exposed to biologics in utero, gastroenterology societal guidelines have either recommended a …
Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception.
Martini Rodrigues CC, Fernandes EG, Dos Santos PP, Eguti RY, Pedroso-de-Lima AC, da Silva GT, Sartori AMC. Martini Rodrigues CC, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2063594. doi: 10.1080/21645515.2022.2063594. Epub 2022 Apr 19. Hum Vaccin Immunother. 2022. PMID: 35439100 Free PMC article.
Although safe, rotavirus vaccines have been associated with increased intussusception risk. In Brazil, after the oral human rotavirus vaccine (OHRV) introduction in the childhood immunization, in 2006, increased intussusception risk was identified afte …
Although safe, rotavirus vaccines have been associated with increased intussusception risk. In Brazil, after the oral human …
Routine Childhood Vaccines Given in the First 11 Months of Life.
Jacobson RM. Jacobson RM. Mayo Clin Proc. 2020 Feb;95(2):395-405. doi: 10.1016/j.mayocp.2019.06.007. Epub 2019 Dec 24. Mayo Clin Proc. 2020. PMID: 31879133 Review.
The first dose is due at birth. This series protects against maternal-infant transmission of the HepB virus and against exposure the rest of the infant's life. ...At 4 months, infants are to repeat those vaccines except for the HepB va
The first dose is due at birth. This series protects against maternal-infant transmission of the HepB virus and against exposure
74 results